在癌症免疫疗法中应用工程性树突细胞疫苗:挑战和机遇
Ping Li1, Linan Jia2, Xiaobo Bian3
1Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Current treatment options in oncology
|November 14, 2023
概括
使用转基因树突细胞 (DCs) 的癌症疫苗显示出改变免疫疗法的前景. 本综述分析了DC功能,临床整合,以及加强癌症治疗策略的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 树突细胞 (DCs) 是重要的免疫调节体.
- DCs在启动和塑造适应性免疫反应中发挥着关键作用.
- 它们的功能是开发有效的癌症免疫疗法的核心.
研究的目的:
- 评估使用转基因树突细胞 (DCs) 的癌症疫苗的有效性.
- 分析DCs在诱导针对癌症的转变性免疫反应中的作用.
- 探索基于DC的疫苗在临床癌症治疗中的整合.
主要方法:
- 关于DC疫苗的临床前研究的全面审查.
- 对基于DC的免疫疗法临床实施策略的分析.
- 检查DC疫苗开发中的挑战和机会.
主要成果:
- 树突细胞 (DCs) 显示出显著的潜力来增强癌症免疫疗法.
- 将DC疫苗与现有药品结合使用可能会产生协同效应.
- 该研究强调了基于DC的方法在瘤学中的变革潜力.
结论:
- 转基因树突细胞 (DC) 疫苗为彻底改变癌症治疗提供了一个有希望的途径.
- 克服技术,监管和实施方面的挑战对于成功的临床翻译至关重要.
- 包括组合疗法在内的整体方法对于最大限度地提高治疗疗效至关重要.
更多相关视频
相关概念视频
Cancer Vaccines
380
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
380
Tumor Immunotherapy
533
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
533


